HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
When do Hydrocodone Bitartrate And Chlorpheniramine Maleate patents expire, and what generic alternatives are available?
Hydrocodone Bitartrate And Chlorpheniramine Maleate is a drug marketed by Acella and Tris Pharma Inc and is included in two NDAs.
The generic ingredient in HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate; hydrocodone bitartrate. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE?
- What are the global sales for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE?
- What is Average Wholesale Price for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE?
Summary for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
DailyMed Link: | HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE at DailyMed |
US Patents and Regulatory Information for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acella | HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE | chlorpheniramine maleate; hydrocodone bitartrate | SOLUTION;ORAL | 206891-001 | Jun 9, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Tris Pharma Inc | HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE | chlorpheniramine maleate; hydrocodone bitartrate | SOLUTION;ORAL | 206438-001 | Jan 27, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |